1/106
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
biopsychosocial model
Drug-taking behavior is best accounted for by a combination of biological, psychological, and sociological factors
ex: genetic predisposition for alcoholism + mental health disorder + pressure from peers = higher risk
drug
chemical substance that, when taken into the body, alters the structure or functioning of the body in some way EXCLUDING those nutrients considered to be related to normal functioning
AND, if the intended purpose is to induce bodily or psychological change
psychoactive drugs
chemical substances that alter our feelings, thoughts, perceptions of the world, and behaviors
instrumental use vs. recreational use
brand name
drug name given by pharmaceutical manufacturer who has the rights to marketing that drug
ex: Tylenol, Zoloft, Zyrtec
generic name
name of a drug that does not belong to a specific brand
ex: acetaminophen, heroin, methampetamine
natural-product name
drug name referring to the plant or chemical from which the drug was derived
ex: marijuana, morphine
street name
drug name referring to slang terms generated by users of that drug
ex: speed, coke, weed
sociocultural factors
what determines whether a drug is legal or illegal?
ex: history, culture, and religion
drug misuse
instrumental goal, but used inappropriately
drug abuse
usually recreational goal, used to produce physical, mental, or social impairment
drug dependence
intense cravings, preoccupation with obtaining the drug, high tolerance and withdrawal
drug origins
shamanism (~10000BC) and priestly healing (~1500 BC)
opium
cocaine
fly agaric
opium
found in poppies, likely consumed or applied to wounds
part of drug origins
cocaine
found in coca leaves, consumed for pain relief and energy boosts
part of drug origins
fly agaric
found in mushrooms, ate by vikings before battle, gave them extreme levels of energy
part of drug origins
late 1800’s
medicinal developments
morphine prescribed as effective pain reliever
cocaine used a stimulant and antidepressant
anesthetics discovered
vaccine development (rabies, smallpox)
social developments
widespread and uncontrolled access to psychoactive drugs
early 1900’s
promising medicinal developments and concern over dependency
18th amendment- prohibition
eventually overshadowed by negative social changes
1945-1960
medicinal developments
“psychiatric revolution” in the 50’s
social developments:
Post WWII
Cocktail parties, smoking rates peak
1960’s-1990’s
fallout from the Cold War and Vietnam War
result- heavy drug experimentation
war on drugs (Nixon, 1968)
Controlled Substances Act (1970)
Neuroscience field established (70s)
Controlled Substances Act
five schedules for the classification of drugs
based on approved medicinal uses, potential for abuse, and potential for dependence
Schedule I
most potential for abuse and dependence
no medicinal qualities
ex: heroin, LSD, marijuana, ectasy, peytoe
Schedule 2
high potential for abuse and dependence
some medicinal qualities
ex: Vicodin, cocaine, meth, OxyContin, Adderall
Schedule 3
Moderate potential for abuse/dependence
Acceptable medicinal qualities
doctor’s prescription required
Ex: Tylenol with Codeine, Ketamine, Steroids, Testosterone
Schedule 4
low potential for abuse and dependence
acceptable medicinal qualities
prescription required— fewer refill regulations
ex: Xanax, Darvon, Vallum, Ativan, Ambien, Tramadol
Schedule 5
lowest potential for abuse/dependence
acceptable medicinal qualities
prescription required—fewest refill regulations
ex: Robitussin aC, Lomotil, Motofen, Lyrica
Early 2000’s
Bush- war on terrorism, increased control over drug trafficking
programs for drug abuse + programs for national security
National Survey of Drug Use and Health
an annual nationwide study that provides up-to-date data on tobacco, alcohol, and illicit drug use, mental health conditions, and substance use or mental health treatment in the United States
over- and under reporting assumed
Monitoring the Future
survey is an ongoing, long-term study that tracks substance use, behaviors, and values among American adolescents and adults.
over-and under reporting assumed
high school students
drug use peaked in ‘79 and ‘81
drug use hit lowest point in ‘91 and ‘93
alcohol use more steady-highest in 70’s (laws)
overall decrease in cigarette use, slight peak in late in late 90s
college students
marijuana men use more than women (now changed)
alcohol- steady has decreased throughout past 30 years (women uses more than men)
cigarette use- consistent decline
risk factors
circumstances that increase the likelihood of drug-taking behavior
ex:
antisocial behaviors (e.g. getting into fights)
having friends who use or believing that they do
personal positive views of drug use
friends positive views of drug use
Low SES
protective factors
circumstances that decrease the likelihood of drug-taking behaviors
ex:
perceived risk of punishment
high social support/parental support
commitment to school
religiosity
extracurricular involvement
high SES
odds ratio
statistically determining risk and protective factors
= # of “yes” responses/ # of “no” responses
Ratio > = risk factor
Ratio < = protective factor
Ratio = 1 = no factor
DSM-5 Diagnosis
taking the substance in larger amounts and for longe than intended
wanting to cut down or quit substance use but not being able to do it
spending a lot of time obtaining the substance
craving or having a strong desire to engage in substance use
repeatedly being unable to carry out major obligations at work, school, or home due to substance use
continued use despite persistent or recurring social or interpersonal problems caused or made worse by substance use
stopping or reducing important social, occupational, or interpersonal activities due to substance
withdrawal
tolerance
substance use disorder
4 categories
impaired control
social impairment
risky sue
pharmacological effects
drug-taking behavior
actions and their consequences regarding acquiring a drug, taking a drug, and responding to a drug
Effective dose
the minimal dose of a drug necessary to produce the intended drug effect in a given percentage of the population
ex: ED50- effective dose for 50% of the population
lethal dose
the minimal dose of a drug that would be lethal to a given percentage of the population
ex: LD50- lethal dose for 50% of the population
therapeutic index
the ratio of a lethal dose for 50% of the population to the effective dose for 50% of the population (LD50/ED50)
ex: a drug with an LD50 of 500 mg and an ED50 of 50 would have a TI of 10
the smaller, the more dangerous it is
margin of safety
the ratio of a lethal dose for 1% of the population to the effective dose fo 99% of the population (LD1/ED99)
ex: a drug with an LD1 of 400 mg and en ED99 of 100 would have a MS of 4
the smaller, the more dangerous it is
toxicity
a risk of physical or psychological harm for a drug user
relative
alcohol
results in the most drug-related ER visits
tolerance
with repeated administrations, you need a higher dose of a drug to achieve the same effect
behavioral tolerance
tolerance that occurs when drug-taking behavior consistently takes place in the same surroundings or under the same circumstances
Siegel’s study
results: rats tested in the same room that they were trained in had lower mortality rates (32%) than rats tested in different room than they were trained in (64%)
conclusion: environmental cues can somewhat compensate for some of the effects of a drug
the less similar, the more likely an accidental overdose will occur
physical dependence
avoiding the physical symptoms of withdrawal
avoiding punishment
psychological dependence
craving the pleasurable effects of the drug
craving reinforcement
drug-defined crimes
violations of a law that prohibits the possession, distribution, or manufacturing of a drug
ex: possession of cocaine
drug-related crimes
violations of a law that is not a drug law through an act that involves drug
ex: physical assault while on drugs
tripartite model
model for drugs and violence
pharmacological violence
economically compulsive violence
systemic violence
pharmacological violence
violence committed by an individual while under the direct influence of a psychoactive drug
ex: committing aggravated assault while high on cocaine
confounds:
not all drugs make people aggressive
people who are more aggressive might be more likely to do drugs
doing drugs and committing crimes have similar risk factors
economically compulsive violence
violence committed for the purpose of securing money to buy drugs or securing drugs without paying
ex: robbing someone for drug money
evidence:
property crime increases when drug prices are high
opioid prices peaked in 2012, pharmacy robberies peaked in 2012
systemic violence
violence that arises from patterns of aggression within an organization involved in illicit drug trafficking and distribution (usually gangs)
ex: drug trafficking gangs
evidence:
gang member who sell drugs tend to be more violent than member who dont sell drugs and more violent than drug sellers who aren’t in a gang
pure food and drug act
governmental policy
required food and drug manufactures to list the amounts of alcohol or “habit-forming” drugs on their product labels
harrison act
governmental policy
required anyone importing, manufacturing, selling, or dispensing opium-related drugs (narcotics) or cocaine to register with the Treasury Department, pay a tax, and keep record of all transactions
marijuana tax act
governmental policty
required growers, sellers, and buyers of marijuana to pay a tax
anti-drug abuse act
governmental policies
penalized money laundering when associated with drug smuggling and sales
current government policy
supply side approach- reduce drug availability
demand side approach - reduce inclination to seek out drugs
Moving from “zero tolerance” to “harm reduction”
money laundering
smurfing
offshore bank accounts
use of retail service establishments (laundromats)
pharmacokinetics
how drugs move throughout the body
4 principles
absorption
distribution
metabolism
elimination
absorption
how a drug enters the bloodstream once administered
4 main routes
oral
injection
IV, IM, and SC
inhalation
through skin or membranes
oral administration
eating or drinking a substance
ex: alcohol, edible marijuana, caffeine
pros
slow absorption (30-60 minutes)
cons
slow absorption
natural barriers of digestion
highly variable/less predictable
injection
through hypodermic needle
intravenous- (IV) needle in vein (fastest)
ex: heroin, cocaine, meth, morphine
intramuscular (IM)- needle in muscle
ex: vaccines
subcutaneous (SC)- needle in tissue just underneath skin
ex: heroin, some opioids
pros
fast absorption (~10 seconds)
immediate effects
cons
fast absorption (high overdose risk)
risk of skin irritation
potential blood clots
needles must be sterile
inhalation
breathing smoke-borne particles and gases into lungs
ex: nicotine, crack, marijuana, anesthetics
pros
fast absorption (~2-3 seconds)
large surface area (lungs)
cons
fast absorption
effect only while drug is being inhaled
long term risks (lung cancer, asthma)
throat/nasal irritation
through skin membranes
positioning drug against skin or membranes (intranasal, transdermal, etc.)
ex: nicotine patches, cocaine, zyn
pros
sustained delivery
controllable administration
cons
skin/membrane irritation
certain drugs can’t penetrate skin
rates of absorption
inhalation (fastest)
injection
IV
IM
SC
Absorption through skin/membranes
Oral (slowest)
distribution
how a drug moves throughout the body
blood-brain barrier
barrier between the brain and bloodstream that restricts the passage of certain drugs and molecules into the brain
what drugs/molecules can pass
fat soluble
ex: nicotine, alcohol, cocaine, caffeine
very small
ex: oxygen, anesthetics
has a specialized transporter protein (active transporter)
ex: glucose, amino acids, vitamins
metabolism
how the molecular structure of a drug is changed to make excretion easier
biotransformation
the chemical alteration of a substance within the body
typically occurs via liver enzymes
elimination half-life
the amount of time it takes for a drug to decline to 50$ of its original concentration level in the bloodstream
a drug is considered “eliminated” after 4-5 half-lives
underlying factors of drugs
timing
initial latency period, side effects when drug effect peaks
solution-time-release drugs
drug interactions
additive effects
antagonistic effects
additive effects
the combined effect of multiple drugs is greater than either drug on its own
ex: alcohol with barbiturates
antagonistic effects
the individual effect of a drug is somewhat diminished when administered with another drug
ex: heroin with Narcan
cross-tolerance
when the tolerance to one drug induces a tolerance effect to another drug that hasn’t been taken before
ex: someone who abuses sedatives may need a higher dose of anesthetics
cross-dependence
when the withdrawal symptoms of one drug are relieved by administering another drug
ex: quitting alcohol but using a barbiturate instead
peripheral nervous system
nerves and nerve fibers
splits into
somatic nervous system (voluntary muscles)
autonomic nervous system (involuntary muscles)
sympathetic nervous system
uses energy; subgroup of autonomic nervous system
stimulants
heart racing
fast breathing
pupils dilated
dry mouth
loss of bladder control
adrenaline increases
no digestion
parasympathetic nervous system
restores energy; subgroup of autonomic nervous system
depressants
heart slowing
slowed breathing
pupils constricted
increased salivation
bladder constriction
no adrenaline
increased digestion
neurons
cell of the nervous system that receive and transmit information
dendrite
part of neuron that receives information
axon
part of neuron that transmits information
action potential
electrical impulse that can trigger the release of neurotransmitters
synpatic cleft
gap between neurons
vesicles
containers for neurotransmitters in the presynaptic cell
neurotransmitter
chemical compounds used by neurons to communicate (chemical messengers)
7 main
acetylcholine
norepinephrine
dopamine
serotonin
GABA
Glutamate
Endorphins
receptor
proteins on the membrane of a postsynaptic cell that receive neurotransmitters from presynaptic cells
neurotransmission
neurotransmitter release
receptor binding (selective; excitatory; inhibitory)
reuptake or degradation
acetylcholine
neurotransmitter involved in parasympathetic nervous system regulation, motor functions
receptors: cholinerergic receptors (muscarinic and nicotininc)
norepinephrine
neurotransmitter involved in sympathetic nervous system regulation, mood regulation
Receptors: adrenoceptors (alpha-1, alpha-2, beta-1, beta-2)
dopamine
neurotransmitter involved in motor control, emotionality, reward/reinforcement
Receptors: dopaminergic receptors (D1-D5)
serotonin
neurotransmitter involved in sleep and wakefulness, mood regulation
Receptor: 5HT receptors (5HT1-7)
GABA
neurotransmitter involved in inhibitory, fear/stress reduction
receptors: GABAergic receptors (GABA-A and GABA-B)
Glutamate
neurotransmitter involved in excitatory, cravings
receptors: glutamatergic receptors (NMDA, AMPA, kainate, mGluRs)
endorphins
neurotransmitter involved in natural painkillers
receptors: opioid receptors (mu, delta, kappa, NOP)
neuropeptide
amino acids
Glutamate
GABA
Aspartate
Glycine
monoamines
catecholamines
Dopamine
Norepinephrine
Epinephrine
Indolamines
Serotonin
soluble gases
nitric oxide
carbon monoxide
metabolic tolerance
increased amount of enzymes that metabolize that drug
larger drug dose is needed to reach same blood concentration
pharmacodynamic tolerance
reduced number of receptors or sensitivity of receptors for that drug
same blood concentration, but less effective